Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection
NCT05082441
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Benign Neoplasm
Interventions
DRUG:
Liposomal bupivacaine
DRUG:
Bupivacaine Hydrochloride
Sponsor
Samaritan Health Services